Cordlife Group (SG:P8A) has released an update.
Cordlife Group Limited has received a fifth communication from SAC Capital, on behalf of Nanjing Xinjiekou Department Store Co., Ltd., expressing continued monitoring of the company’s situation following the Ministry of Health’s directive to halt new cord blood services. The focus is on the financial impact of the suspension and the company’s efforts to comply with health regulations to resume operations.
For further insights into SG:P8A stock, check out TipRanks’ Stock Analysis page.
